G03-52-01
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for G03-52-01, covering 2024-10-04 to 2026-02-17. Get the full timeline:
Most recent: Clinical Trial Update: Single or Repeat Dose of G03-52-01 in Adult Subjects [Phase 2]